Pharmaceutical giant GSK fined alongside a raft of other firms for «stifling» competition for depression drug (legalweek.com)
[CEO] Richard Pops has got a major medical depression drug and I think it's worth — definitely, because the FDA is going to review it — it's worth a buy. (cnbc.com)
That's particularly unfortuante for Cerecor seeing as CERC - 501 is the company's lead drug candidate — and the news comes just days after Cerecor announced that a separate experimental depression drug called CERC - 301 had also failed in the clinic. (fortune.com)